Abstract
The Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM) trial (N Engl J Med 2012; 367:2375-2384) was designed to resolve the long-standing debate over the optimal revascularization strategy in patients with diabetes mellitus and multivessel coronary artery disease. At a median follow-up of 3.8 years, the incidence of the primary outcome (a composite of death, myocardial infarction, and stroke) was significantly lower with bypass surgery than with percutaneous intervention.
Original language | English (US) |
---|---|
Pages (from-to) | 515-523 |
Number of pages | 9 |
Journal | Cleveland Clinic journal of medicine |
Volume | 80 |
Issue number | 8 |
DOIs | |
State | Published - 2013 |
ASJC Scopus subject areas
- Medicine(all)